Abstract:PURPOSE: Split thickness skin graft (STSG) implantation is one of the standard therapies for full thickness wound repair when autologous skin full thickness graft (FTG) or skin flap transplants are inapplicable. However, STSG are more fragile than FTG and can contract significantly during the healing process. Human mesenchymal stem cells (hMSCs) are capable of accelerating the wound healing process. So we use pre-vascularized hMSC sheets (PHCS) to study if they would further improve the repair quality of STSG. METHODS:In vitro cultured control hMSC cell sheets (HCS) were obtained after four weeks culture in complete culture medium (CCM), then endothelial cells (ECs) were cocultured on top of the hMSC sheets for 1 week to get PHCS. Immunofluorescence staining was used to characterize both cell sheets. The progenitor population and multi-lineage differentiation ability of hMSCs inside the cell sheets were tested. The angiogenic growth factor amount present in the cell sheets was also analyzed using an enzyme-linked immunosorbent assay (ELISA). The cell sheets were applied in combination with an autologous STSG in rats with full thickness skin wound. Graft survival and contraction was evaluated and the implants were harvested at predetermined time points for analysis (n=6 animals per group). Histology and immunohistochemistry were performed to test if PHCS can enhance the therapeutic effects of STSG. RESULTS: The hMSCs in HCS still maintain self-renewal and differentiation capacity after extended periods of culture. The TGF-β1, ANG1 and ANG2 amount in PHCS was higher than HCS (p<0.05) whereas the VEGF amount in PHCS was significantly lower than that in HCS (p<0.05). The HCS and the PHCS implantation significantly reduced skin contraction and improved cosmetic appearance relative to the STSG control group. The PHCS group experienced the least hemorrhage and necrosis, and lowest inflammatory cell infiltration. It also induced the highest neovascularization in early stages, which established a robust blood micro-circulation to support grafts survival and tissue regeneration. Moreover, the PHCS grafts preserved the largest amount of skin appendages (including hair follicles and sebaceous glands) and developed the smallest epidermal thickness. The collagen deposition and fibril morphology in PHCS grafts were also similar to normal skin, indicating a lower degree of skin fibrosis. The superior therapeutic effect seen in PHCS groups was attributed to the elevated presence of growth factors and cytokines in the pre-vascularized cell sheet, which exerted a beneficial paracrine signaling during the early stage of wound repair. CONCLUSION: The strategy of combining autologous STSG with PHCS implantation appears to be a promising approach in regenerative treatment of full thickness skin wounds.

PF-127 hydrogel plus sodium ascorbyl phosphate improves Wharton's jelly mesenchymal stem cell-mediated skin wound healing in mice

Thermosensitive hydrogel coupled with sodium ascorbyl phosphate promotes human umbilical cord-derived mesenchymal stem cell-mediated skin wound healing in mice

Wharton’s jelly mesenchymal stem cells embedded in PF-127 hydrogel plus sodium ascorbyl phosphate combination promote diabetic wound healing in type 2 diabetic rat

Histological, immunohistochemical, and genomic evaluation of excisional and diabetic wounds treated with human Wharton's jelly stem cells with and without a nanocarrier

Human adipose-derived mesenchymal stem cells-derived exosomes encapsulated in pluronic F127 hydrogel promote wound healing and regeneration

Enhancing Skin Injury Repair: Combined Application of PF-127 Hydrogel and hADSC-Exos Containing miR-148a-3p

Conditioned Medium from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Accelerates Cutaneous Wound Healing Through Enhanced Angiogenesis.

Pluronic F127 composite hydrogel for the repair of contraction suppressed full-thickness skin wounds in a rabbit model

Transplantation of Wharton's jelly mesenchymal stem cells encapsulated with Hydroactive® Gel promotes diabetic wound antifibrotic healing in type 2 diabetic rats

In Situ-Formed Fibrin Hydrogel Scaffold Loaded With Human Umbilical Cord Mesenchymal Stem Cells Promotes Skin Wound Healing

SA/G hydrogel containing NRF2-engineered HEK-293-derived CM improves wound healing efficacy of WJ-MSCs in a rat model of excision injury

Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes Combined Pluronic F127 Hydrogel Promote Chronic Diabetic Wound Healing and Complete Skin Regeneration

Platelet Poor Plasma Gel Combined with Amnion Improves the Therapeutic Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells on Wound Healing in Rats

MSC-derived exosomes attenuate cell death through suppressing AIF nucleus translocation and enhance cutaneous wound healing

Abstract P21: Enhancement of Therapeutic Benefits of Split Thickness Skin Grafts Using Pre-vascularized Human Mesenchymal Stem Cells

Pre-vascularization Enhances Therapeutic Effects of Human Mesenchymal Stem Cell Sheets in Full Thickness Skin Wound Repair

Combination therapy of placenta-derived mesenchymal stem cells and artificial dermal scaffold promotes full-thickness skin defects vascularization in rat animal model

Hydrogel loaded with exosomes from Wharton ' s Jelly-derived mesenchymal stem cells enhances wound healing in mice

Large-scale Expansion of Wharton's Jelly-Derived Mesenchymal Stem Cells on Gelatin Microbeads, with Retention of Self-Renewal and Multipotency Characteristics and the Capacity for Enhancing Skin Wound Healing.

An investigation of a self-assembled cell-extracellular complex and its potentials in improving wound healing

Advanced phosphocreatine-grafted chitosan hydrogel promote wound healing by macrophage modulation